Safety Set

Statistical Hypotheses: Null and alternative hypotheses stated for primary and secondary endpoints

Statistical Tests Used: E.g., t-tests, ANOVA, Cox regression, Chi-square

Multiplicity Handling: Bonferroni, Holm’s method, or hierarchical testing

Imputation Methods: Last Observation Carried Forward (LOCF), Multiple Imputation

Subgroup Analyses: Based on demographics, geographic regions, baseline severity

Best practice: Avoid overly technical jargon. Use footnotes or appendices if needed for complex equations or software-specific terms (e.g., SAS, R).

Checklist for the Statistical Methods Section:

• Align with SAP section numbers
• Specify software and version used
• List protocol deviations and their impact
• Include interim analysis procedures (if any)
• Maintain parallel structure with efficacy and safety results

Having a robust SOP helps synchronize SAP references, TLF call-outs, and CSR text. See examples at GMP SOP documentation.

Structure of the Statistical Results Section:

Present results in a clear, logical sequence:

1. Subject Disposition: Include disposition table and percentages for completed vs. discontinued subjects
2. Baseline Characteristics: Age, gender, ethnicity, BMI, baseline lab parameters
3. Primary Endpoint: Numerical summary with confidence intervals, p-values, and effect size
4. Secondary Endpoints: Ordered by importance; include TLF references
5. Subgroup Analyses: Consistency of effect, forest plots if available
6. Safety Analysis: Adverse events, lab abnormalities, vital signs, ECGs

Best Practices for Writing Statistical Results:

• Use declarative language, e.g., “Mean change from baseline was 4.2 (95% CI: 3.1–5.3)”
• Refer directly to tables and figures in the text
• Highlight clinically significant findings separately
• Discuss data trends, not just numbers

Support safety summaries with MedDRA-coded data and standardized tables. Avoid duplicating data already shown in listings.

Ensuring Traceability and Consistency:

Regulators expect consistent flow from SAP → TLFs → CSR. Apply these traceability practices:

• Annotate tables and listings with CSR section references
• Use exact titles from TLFs when citing
• Label sensitivity and exploratory analyses clearly
• Maintain analysis population flags throughout

Using validation master plans ensures consistent statistical result reporting across trials.

Common Mistakes and How to Avoid Them:

1. Omitting Unplanned Analyses: Always report, but clearly mark as exploratory
2. Mixing Safety and Efficacy Data: Keep them in separate sections
3. Ignoring SAP Deviations: Disclose and justify deviations in a transparent way
4. Overusing Acronyms: Define each at first mention
5. Copying Table Content Verbatim: Summarize key messages; don’t restate raw data

Run your document through a structured QC cycle. Reference your regulatory compliance SOPs to confirm format and content completeness.

Final Tips for Quality Statistical Writing:

• Plan TLF delivery timelines with the biostatistics team
• Use consistency checks for numbers across CSR and TLFs
• Allow at least two internal review cycles
• Label draft versions clearly and track changes
• Use CSR templates compliant with ICH E3

Also, stay updated with statistical reporting trends from agencies like TGA or CDSCO.

Conclusion:

Writing the statistical methods and results sections of CSRs requires a balance of accuracy, regulatory compliance, and reader-friendly language. Proper planning, collaboration with statisticians, and use of templates ensures consistency and efficiency.

Use this tutorial as a reference when preparing your next CSR. With attention to detail, structure, and regulatory expectations, your report will stand up to the highest scrutiny from health authorities worldwide.